Common Cold and Acute Rhinosinusitis: Up-to-Date Management in 2020

AbstractPurpose of ReviewThe purposes of the review are as follows: (1) to define acute rhinosinusitis (ARS) and their phenotypes, (2) to highlight the ARS management according to international guidelines, (3) to compare the physicians ’ management with the ARS guideline recommendations, and (4) to report ARS socioeconomic burden.Recent FindingsBacterial and non-bacterial ARS have similar symptoms, although they can be discriminated by using a combination of specific signs and symptoms. The prescription of antibiotics should be limited to clearly suspected bacterial ARS. There is an overuse of diagnosis tools and treatment prescriptions. The total cost per ARS episode in Europe is over €1000.SummaryARS is mainly an inflammatory disease triggered by viral infection, and few cases end up developing bacterial infection. In most of the cases, it is a self-resolving disease which diagnosis is mainly clinical and the treatment symptomatic. The incidence of complications is low and independent of antibiotic use. There is a high socioeconomic burden associated to ARS.
Source: Current Allergy and Asthma Reports - Category: Allergy & Immunology Source Type: research